These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9292651)

  • 1. Clear clinical remission of a diffuse metastasized ovarian clear cell carcinoma with third line chemotherapy.
    Debois JM
    Acta Obstet Gynecol Scand; 1997 Aug; 76(7):709-12. PubMed ID: 9292651
    [No Abstract]   [Full Text] [Related]  

  • 2. Remarkable suppressive effect of consecutive low-dose cisplatin therapy on advanced ovarian clear cell adenocarcinoma.
    Umesaki N; Tanaka T; Kawamura N; Miyama M; Ichimura T; Ogita S
    Oncol Rep; 1999; 6(5):1035-7. PubMed ID: 10425299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of chemotherapy for clear cell adenocarcinoma of the ovary].
    Okubo T; Takeda S; Ikeba K; Takagi Y; Ishihara O; Seki H; Kinoshita K
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1279-83. PubMed ID: 9279347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic analysis of 88 patients with ovarian clear cell carcinoma].
    Ma SK; Zhang HT; Wu LY; Liu LY
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):784-8. PubMed ID: 18396695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leiomyosarcoma with synchronous clear cell ovarian carcinoma.
    Rettenmaier M; Epstein HD; Abaid LN; Bechtol KA; Goldstein BH
    Onkologie; 2010; 33(12):695-7. PubMed ID: 21124041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of brain metastasis from advanced ovarian clear-cell carcinoma during maintenance chemotherapy with irinotecan+cisplatin].
    Takami M; Kita E; Kuwana Y; Ohta Y; Nakayama Y; Fukai H; Matsumoto H; Takimoto T; Ichikawa G; Yamamoto T
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1243-5. PubMed ID: 18633273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of chemotherapy successfulness of platina/taxol chemotherapy protocol by using determination of serum urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) in patients with ovarian carcinoma FIGO II and III stage.
    Ljuca D; Fatusić Z; Iljazović E; Ahmetović B
    Bosn J Basic Med Sci; 2007 May; 7(2):111-6. PubMed ID: 17489744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete remission of recurrent ovarian clear cell carcinoma by chemotherapy with bevacizumab, trabectedin and oxaliplatin.
    Takano M; Ikeda Y; Kudoh K; Kita T; Sasaki N; Kikuchi Y
    J Obstet Gynaecol Res; 2013 Apr; 39(4):872-5. PubMed ID: 23167774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploratory study of effective chemotherapy to clear cell carcinoma of the ovary.
    Kita T; Kikuchi Y; Kudoh K; Takano M; Goto T; Hirata J; Tode T; Nagata I
    Oncol Rep; 2000; 7(2):327-31. PubMed ID: 10671681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case report: endometrial carcinoma response to intraperitoneal and intraarterial chemotherapy].
    Itagaki T; Furusawa Y; Sasaki Y; Kurihara H; Mitsukawa G
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1326-9. PubMed ID: 9703819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of advanced ovarian clear cell adenocarcinoma responding to cisplatin-cyclophosphamide and paclitaxel-carboplatin].
    Iwasaki K; Komuro Y; Masumoto N; Asaoka K; Ishitani K
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1483-6. PubMed ID: 10500539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete response to irinotecan hydrochloride and nedaplatin in a patient with advanced ovarian clear cell carcinoma.
    Nishida M; Tsunoda H; Ichikawa Y; Yoshikawa H
    Int J Clin Oncol; 2004 Oct; 9(5):403-5. PubMed ID: 15549593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease.
    Ho CM; Huang YJ; Chen TC; Huang SH; Liu FS; Chang Chien CC; Yu MH; Mao TL; Wang TY; Hsieh CY
    Gynecol Oncol; 2004 Jul; 94(1):197-203. PubMed ID: 15262142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Camptothecin and mitomycin combination chemotherapy on ovarian clear cell carcinoma with multiple systemic metastases.
    Tanaka T; Umesaki N; Ogita S
    Eur J Gynaecol Oncol; 2000; 21(4):377-9. PubMed ID: 11055487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of topoisomerase IIalpha (Topo IIalpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas.
    Koshiyama M; Fujii H; Kinezaki M; Morita Y; Nanno H; Yoshida M
    Anticancer Res; 2001; 21(4B):2925-32. PubMed ID: 11712788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of ovarian cancer with Parkinson's disease treated by combined chemotherapy with paclitaxel and carboplatin followed by surgery].
    Furukawa M; Fujiwara H; Urabe S; Egawa M; Fujitoh N; Sakashita T; Date K; Mizunoe T; Ueda K; Urabe T
    Gan To Kagaku Ryoho; 2003 Dec; 30(13):2129-32. PubMed ID: 14712777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-line chemotherapy in recurrent clear cell ovarian cancer: results from the multicenter italian trials in ovarian cancer (MITO-9).
    Esposito F; Cecere SC; Magazzino F; Katsaros D; Ottaiano A; Gadducci A; Pisano C; Scalone S; Rabaiotti E; Salutari V; Cormio G; Canuto EM; Greggi S; Savarese A; Marinaccio M; Scollo P; Santeufemia DA; Sacco C; Facchini G; Pignata S
    Oncology; 2014; 86(5-6):351-8. PubMed ID: 24942520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete response to radiation therapy in a patient with chemotherapy-resistant ovarian clear cell adenocarcinoma.
    Takai N; Utsunomiya H; Kawano Y; Nasu K; Narahara H; Miyakawa I
    Arch Gynecol Obstet; 2002 Dec; 267(2):98-100. PubMed ID: 12439556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel-platinum combination chemotherapy for advanced or recurrent ovarian clear cell adenocarcinoma: a multicenter trial.
    Utsunomiya H; Akahira J; Tanno S; Moriya T; Toyoshima M; Niikura H; Ito K; Morimura Y; Watanabe Y; Yaegashi N
    Int J Gynecol Cancer; 2006; 16(1):52-6. PubMed ID: 16445610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of clear cell carcinoma of the ovary responding to a paclitaxel-carboplatin combination chemotherapy].
    Fujiwara K; Maehata K; Kohno I; Yoden E; Imajo Y; Mikami Y
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2259-62. PubMed ID: 11142173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.